Table 3.
Aqueous Factors/Cytokines | sVEGFR-1 (pg/mL) | sVEGFR-2 (pg/mL) | VEGF (pg/mL) | PlGF (pg/mL) |
PDGF-AA (pg/mL) | sICAM-1 (pg/mL) | MCP-1 (pg/mL) | IL-6 (pg/mL) |
IL-8 (pg/mL) |
IL-12 (p70) (pg/mL) | IL-13 (pg/mL) |
IP-10 (pg/mL) |
---|---|---|---|---|---|---|---|---|---|---|---|---|
At Recurrence (median (interquartile range)) |
493 (274–912) |
503 (333–643) |
49.5 (1.60–105) |
2.64 (2.02–5.26) |
20.2 (13.8–28.2) |
3.64 (1.20–8.35) |
1139 (909–1362) |
1.75 (0.64–3.13) |
11.5 (8.13–18.5) |
0.61 (0.22–2.43) |
0.48 (0.10–1.62) |
74.2 (42.2–92.3) |
Variable |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
r p value |
Arterial of the non-occluded region | −0.04 0.873 |
0.30 0.231 |
0.02 0.943 |
−0.03 0.919 |
−0.13 0.601 |
0.08 0.001 |
0.46 0.753 |
−0.04 0.862 |
−0.03 0.906 |
0.11 0.656 |
0.07 0.788 |
0.01 0.961 |
Arterial of the occluded region | −0.04 0.865 |
0.29 0.178 |
−0.20 0.427 |
−0.11 0.671 |
−0.16 0.528 |
0.33 0.182 |
0.30 0.222 |
−0.03 0.918 |
−0.01 0.957 |
0.08 0.761 |
0.19 0.443 |
0.01 0.987 |
Venous of the non-occluded region | −0.12 0.628 |
0.20 0.349 |
−0.27 0.277 |
−0.04 0.871 |
0.10 0.691 |
0.20 0.440 |
0.24 0.341 |
0.20 0.436 |
0.11 0.662 |
0.21 0.404 |
0.19 0.381 |
0.18 0.461 |
Venous of the occluded region | −0.04 0.879 |
0.10 0.703 |
−0.03 0.921 |
−0.23 0.358 |
0.26 0.302 |
0.01 0.956 |
0.04 0.887 |
0.16 0.521 |
0.03 0.919 |
0.36 0.085 |
0.15 0.483 |
0.24 0.330 |
sVEGFR = soluble vascular endothelial growth factor receptor; VEGF = vascular endothelial growth factor; PlGF = placental growth factor; PDGF = platelet-derived growth factor; sICAM = soluble intercellular adhesion molecule; MCP = monocyte chemotactic protein; IL = interleukin; r = correlation coefficient. Spearman’s rank-order correlation coefficients were calculated.